These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 1654538)

  • 1. Opioid systems in the response to inflammatory pain: sustained blockade suggests role of kappa- but not mu-opioid receptors in the modulation of nociception, behaviour and pathology.
    Millan MJ; Colpaert FC
    Neuroscience; 1991; 42(2):541-53. PubMed ID: 1654538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of nociception in a model of localized inflammatory pain by long-term administration of naloxone.
    Millan MJ; Colpaert FC
    Prog Clin Biol Res; 1990; 328():331-4. PubMed ID: 2154789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of sustained opioid receptor blockade in a model of long-term, localized inflammatory pain in rats.
    Millan MJ; Colpaert FC
    Neurosci Lett; 1990 May; 113(1):50-5. PubMed ID: 2164176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term blockade of mu-opioid receptors suggests a role in control of ingestive behaviour, body weight and core temperature in the rat.
    Millan MJ; Morris BJ
    Brain Res; 1988 May; 450(1-2):247-58. PubMed ID: 2841004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A model of chronic pain in the rat: functional correlates of alterations in the activity of opioid systems.
    Millan MJ; Członkowski A; Pilcher CW; Almeida OF; Millan MH; Colpaert FC; Herz A
    J Neurosci; 1987 Jan; 7(1):77-87. PubMed ID: 3027278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of mu and kappa opioid systems on motivational processes.
    Shippenberg TS; Herz A
    NIDA Res Monogr; 1986; 75():563-66. PubMed ID: 2829003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The NMDA receptor antagonist MK-801 differentially modulates mu and kappa opioid actions in spinal cord in vitro.
    Feng J; Kendig JJ
    Pain; 1996 Aug; 66(2-3):343-9. PubMed ID: 8880858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinociceptive effects of mu- and kappa-agonists in inflammation are enhanced by a peripheral opioid receptor-specific mechanism.
    Stein C; Millan MJ; Yassouridis A; Herz A
    Eur J Pharmacol; 1988 Oct; 155(3):255-64. PubMed ID: 2853065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonist-induced opioid receptor up-regulation. I. Characterization of supersensitivity to selective mu and kappa agonists.
    Millan MJ; Morris BJ; Herz A
    J Pharmacol Exp Ther; 1988 Nov; 247(2):721-8. PubMed ID: 2846827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that mu-opioid receptors mediate midbrain "stimulation-produced analgesia" in the freely moving rat.
    Millan MJ; Członkowski A; Herz A
    Neuroscience; 1987 Sep; 22(3):885-96. PubMed ID: 2825072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors.
    Stein C; Millan MJ; Shippenberg TS; Peter K; Herz A
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1269-75. PubMed ID: 2539460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation of the hind limb as a model of unilateral, localized pain: influence on multiple opioid systems in the spinal cord of the rat.
    Millan MJ; Członkowski A; Morris B; Stein C; Arendt R; Huber A; Höllt V; Herz A
    Pain; 1988 Dec; 35(3):299-312. PubMed ID: 2906425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrinsic mechanisms of antinociception in inflammation: local opioid receptors and beta-endorphin.
    Stein C; Gramsch C; Herz A
    J Neurosci; 1990 Apr; 10(4):1292-8. PubMed ID: 2158530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of antinociception by peripheral administration of [Lys7]dermorphin, a naturally occurring peptide with high affinity for mu-opioid receptors.
    Negri L; Lattanzi R; Melchiorri P
    Br J Pharmacol; 1995 Jan; 114(1):57-66. PubMed ID: 7712029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of intravenous mu and kappa opioid receptor agonists on sensory responses of convergent neurones in the dorsal horn of spinalized rats.
    Dong XW; Parsons CG; Headley PM
    Br J Pharmacol; 1991 May; 103(1):1230-6. PubMed ID: 1652344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of continuous opioid receptor blockade on alcohol intake and up-regulation of opioid receptor subtype signalling in a genetic model of high alcohol drinking.
    Hyytiä P; Ingman K; Soini SL; Laitinen JT; Korpi ER
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Oct; 360(4):391-401. PubMed ID: 10551276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of sham and full spinalization on the systemic potency of mu- and kappa-opioids on spinal nociceptive reflexes in rats.
    Herrero JF; Headley PM
    Br J Pharmacol; 1991 Sep; 104(1):166-70. PubMed ID: 1664760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulatory activity of mu- and kappa-selective opioid agonists.
    Taub DD; Eisenstein TK; Geller EB; Adler MW; Rogers TJ
    Proc Natl Acad Sci U S A; 1991 Jan; 88(2):360-4. PubMed ID: 1846441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similar actions of kappa and mu agonists on spinal nociceptive reflexes in rats and their reversibility by naloxone.
    Parsons CG; West DC; Headley PM
    NIDA Res Monogr; 1986; 75():461-4. PubMed ID: 2828992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral effects of the kappa-opioid agonist EMD 61753 on pain and inflammation in rats and humans.
    Machelska H; Pflüger M; Weber W; Piranvisseh-Völk M; Daubert JD; Dehaven R; Stein C
    J Pharmacol Exp Ther; 1999 Jul; 290(1):354-61. PubMed ID: 10381799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.